Concepedia

Author

Kai Zhang

Hebei Medical UniversityORCID

Also Known As

Kai Zhang

9

Publications

285

Citations

9

H-Index

18

Concepts

All Affiliations

Hebei Medical UniversityNanjing General Hospital of Nanjing Military CommandNanjing UniversityNanjing Medical UniversityFirst Affiliated Hospital of Chinese PLA General Hospital
KZ

About

Kai Zhang is an author at Hebei Medical University specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

107

2

Natural Sciences

4

4

80

3

Biochemistry

4

4

80

4

Cell Biology

1

1

38

5

Chemical Biology

1

1

16

Kai Zhang

×

9

Publications

285

Citations

9

H-Index

YearCitations

Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway

Kai Zhang, Jing Chen, Dongqin Chen,

Oncotarget

2014

77

A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma

Kai Zhang, Ting Wang, Hao Zhou,

Molecular Therapy — Nucleic Acids

2018

39

Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients

Kai Zhang, Tienian Zhu, Dongmei Gao,

Journal of Cancer Research and Clinical Oncology

2014

38

Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A

Shiyun Cui, Kai Zhang, Chen Li,

Oncotarget

2016

33

Millifolides A–C. New 1,10-Seco-guaianolides from the Flowers of Achillea millefolium

Yong Li, Zhi‐Yu Ni, Meng-Chu Zhu,

Zeitschrift für Naturforschung B

2012

29

Targeting dihydrofolate reductase: Design, synthesis and biological evaluation of novel 6-substituted pyrrolo[2,3-d]pyrimidines as nonclassical antifolates and as potential antitumor agents

Tianfeng Gao, Congying Zhang, Xiaowei Shi,

European Journal of Medicinal Chemistry

2019

22

Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3- d ]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase

Ruijuan Xing, Hongying Zhang, Jiangsong Yuan,

European Journal of Medicinal Chemistry

2017

18

hERG optimizations of IMB1603, discovery of alternative benzothiazinones as new antitubercular agents

Kai Lv, Apeng Wang, Zeyu Tao,

European Journal of Medicinal Chemistry

2019

16

Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of TS and AICARFTase and as potential antitumor agents

Yi Liu, Meng Li, Hongying Zhang,

European Journal of Medicinal Chemistry

2016

13

Page 1